In our study, the JAK/STAT3 signaling pathway was inhibited by NR1D1 over-expression and enhanced by NR1D1 silencing, indicating that the JAK/STAT3 signal may be implicated in the role of NR1D1 in ovarian cancer cells. Here, STAT3 is linked to ovarian carcinoma.